Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fabrazyme pediatric Fabry disease dose-regimen study
2007-005668-28Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2008
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of agalsidase beta in Fabry disease (FD), sponsored by Sanofi. Started Apr 2008; status: completed.
02
Drugs
agalsidase beta
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on 2007-005668-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005668-28.